1. Accelerating Coronavirus Disease 2019 Therapeutic Interventions and Vaccines—Selecting Compounds for Clinical Evaluation in Coronavirus Disease 2019 Clinical Trials. Issue 11 (November 2021) Authors: Buchman, Timothy G.; Draghia-Akli, Ruxandra; Adam, Stacey J.; Aggarwal, Neil R.; Fessel, Joshua P.; Higgs, Elizabeth S.; Menetski, Joseph P.; Read, Sarah W.; Hughes, Eric A. Journal: Critical care medicine Issue: Volume 49:Issue 11(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial. Issue 5 (May 2022) Authors: Self, Wesley H.; Sandkovsky, Uriel; Reilly, Cavan S.; Vock, David M.; Gottlieb, Robert L.; Mack, Michael; Golden, Kevin; Dishner, Emma; Vekstein, Andrew; Ko, Emily R.; Der, Tatyana; Franzone, John; Almasri, Eyad; Fayed, Mohamed; Filbin, Michael R.; Hibbert, Kathryn A.; Rice, Todd W.; Casey, Jonat... Journal: Lancet infectious diseases Issue: Volume 22:Issue 5(2022) Page Start: 622 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗